Linge et al., 2024
Tirzepatide followed as a dual receptor agonist, demonstrating superior weight reduction outcomes compared to semaglutide in head-to-head trials
Weekly doses ranged from 0.5 to 7.2 mg for semaglutide and from 5 to 15 mg for tirzepatide
Study Different Dosages : Since semaglutide is usually prescribed at specific doses for diabetes and weight loss, researchers might test different doses to see which amount provides the best relief for RA symptoms without causing unwanted side effects
And in several recent studies, they show early promise in preventing many common cancers including breast, colon, liver, and ovarian known to be driven by obesity and excess weight
It, too, can cause nausea as a side effect, with 20 percent of people reportedly feeling nauseous during clinical trials